These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33876094)

  • 21. Computational insights into the active structure of SGK1 and its implication for ligand design.
    Akhoon BA; Gandhi NS; Pandey R
    Biochimie; 2019 Oct; 165():57-66. PubMed ID: 31302161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allosteric inhibition of c-Met kinase in sub-microsecond molecular dynamics simulations induced by its inhibitor, tivantinib.
    Yan M; Wang H; Wang Q; Zhang Z; Zhang C
    Phys Chem Chem Phys; 2016 Apr; 18(15):10367-74. PubMed ID: 27029952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. αC helix displacement as a general approach for allosteric modulation of protein kinases.
    Palmieri L; Rastelli G
    Drug Discov Today; 2013 Apr; 18(7-8):407-14. PubMed ID: 23195331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring Molecular Mechanisms of Paradoxical Activation in the BRAF Kinase Dimers: Atomistic Simulations of Conformational Dynamics and Modeling of Allosteric Communication Networks and Signaling Pathways.
    Tse A; Verkhivker GM
    PLoS One; 2016; 11(11):e0166583. PubMed ID: 27861609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1.
    Rettenmaier TJ; Sadowsky JD; Thomsen ND; Chen SC; Doak AK; Arkin MR; Wells JA
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18590-5. PubMed ID: 25518860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of the WNK1 kinase to corneal wound healing using the tissue-engineered human cornea as an in vitro model.
    Desjardins P; Couture C; Germain L; Guérin SL
    J Tissue Eng Regen Med; 2019 Sep; 13(9):1595-1608. PubMed ID: 31207112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
    SarathKumar B; Lakshmi BS
    J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with TrkA kinase.
    Wu X; Li Q; Wan S; Zhang J
    J Biomol Struct Dyn; 2021 Jan; 39(1):202-208. PubMed ID: 31870220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dynamics simulation and free energy calculation studies of kinase inhibitors binding to active and inactive conformations of VEGFR-2.
    Wu X; Wan S; Wang G; Jin H; Li Z; Tian Y; Zhu Z; Zhang J
    J Mol Graph Model; 2015 Mar; 56():103-12. PubMed ID: 25594497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of potential competitive inhibitors against With-No-Lysine kinase 1 for treating hypertension by virtual screening, inverse pharmacophore-based lead optimization, and molecular dynamics simulations.
    Jonniya NA; Sk MF; Roy R; Kar P
    SAR QSAR Environ Res; 2022 Feb; 33(2):63-87. PubMed ID: 35078380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advances in the Discovery of CK2 Allosteric Inhibitors: From Traditional Screening to Structure-Based Design.
    Chen X; Li C; Wang D; Chen Y; Zhang N
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32079098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bitopic Inhibition of ATP and Substrate Binding in Ser/Thr Kinases through a Conserved Allosteric Mechanism.
    Ma N; Lippert LG; Devamani T; Levy B; Lee S; Sandhu M; Vaidehi N; Sivaramakrishnan S
    Biochemistry; 2018 Nov; 57(45):6387-6390. PubMed ID: 30339352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into the binding mode of MEK type-III inhibitors. A step towards discovering and designing allosteric kinase inhibitors across the human kinome.
    Zhao Z; Xie L; Bourne PE
    PLoS One; 2017; 12(6):e0179936. PubMed ID: 28628649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allosteric regulation of the inactive to active state conformational transition in CDPK1 protein of Plasmodium falciparum.
    Gupta P; Mohanty D
    Int J Biol Macromol; 2022 Aug; 215():489-500. PubMed ID: 35709874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening.
    Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
    Vitari AC; Deak M; Morrice NA; Alessi DR
    Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.
    Bestgen B; Krimm I; Kufareva I; Kamal AAM; Seetoh WG; Abell C; Hartmann RW; Abagyan R; Cochet C; Le Borgne M; Engel M; Lomberget T
    J Med Chem; 2019 Feb; 62(4):1803-1816. PubMed ID: 30689953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of CFTR Bicarbonate Channel Activity by WNK1: Implications for Pancreatitis and CFTR-Related Disorders.
    Kim Y; Jun I; Shin DH; Yoon JG; Piao H; Jung J; Park HW; Cheng MH; Bahar I; Whitcomb DC; Lee MG
    Cell Mol Gastroenterol Hepatol; 2020; 9(1):79-103. PubMed ID: 31561038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
    Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
    J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations.
    An X; Bai Q; Bing Z; Liu H; Zhang Q; Liu H; Yao X
    ACS Chem Neurosci; 2020 Feb; 11(4):628-637. PubMed ID: 31968162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.